Top stories on women’s CV health of 2022
Click Here to Manage Email Alerts
Gestational diabetes is associated with a high risk for long-term CV outcomes, according to a presentation at The Pregnancy Meeting this year.
Later in the year, a study published in Hypertension found that nifedipine (Procardia, Pfizer) taken during labor and delivery reduced the need for acute hypertension therapy for women with preeclampsia.
Read these and more top stories about women’s CV health from 2022 below:
Long-term cardiovascular risks greater than expected in gestational diabetes
A greater risk for long-term cardiovascular outcomes was associated with the development of gestational diabetes than previously thought, according to prospective data presented at The Pregnancy Meeting. Read more.
Nifedipine may prevent adverse pregnancy outcomes in women with severe preeclampsia
Women with severe preeclampsia who took nifedipine once daily during labor and delivery were less likely to need fast-acting medicine to control their blood pressure during labor, according to a study published in Hypertension. Read more.
Infertility, pregnancy complications increase risk for future stroke
Infertility and certain pregnancy complications increased women’s risk for stroke later in life, according to an analysis in the BMJ. Read more.
‘Promising’: First trimester neutrophil-to-lymphocyte ratio may predict preeclampsia
A biomarker of systemic inflammation, the neutrophil-to-lymphocyte ratio during the first trimester of pregnancy may predict the development of preeclampsia, data showed. Read more.
Pregnant women with cardiomyopathy at increased risk for adverse outcomes
Adverse maternal and cardiovascular outcomes were more likely in pregnant women with cardiomyopathy compared with those who had a different or no heart disease, findings of a systematic review and meta-analysis showed. Read more.
VIDEO: Considerations for contraception in women with CVD
A recent insight in JAMA highlighted the factors that physicians should consider when counseling women with CVD on contraception. Watch here.
VIDEO: Improving CVD risk prediction in women
Heart disease is a leading health threat for women, according to C. Noel Bairey Merz, MD, FACC, FAHA, FESC, the director of the Barbra Streisand Women’s Heart Institute at Cedars-Sinai. Watch here.
Q&A: Guide recommends CVD risk management strategies after complicated pregnancies
Mothers who experience preeclampsia, preterm delivery, gestational diabetes and other pregnancy complications also may be at increased risk for heart disease, according to researchers at Boston Medical Center. Read more.
Breast arterial calcification may indicate women’s future CV risk
Breast arterial calcification identified during routine mammography was associated with greater risks for coronary artery disease and stroke within 10 years, data published in Menopause show. Read more.
Data support shorter postpartum stay for patients with hypertensive disorders of pregnancy
For patients with hypertensive disorders of pregnancy, there were no significant differences in readmission rates before and after the onset of the COVID-19 pandemic, according to retrospective data presented here. Read more.